Research Article
The Impact of 18F-FDG PET CT Prior to Chemoradiotherapy for Stage III/IV Head and Neck Squamous Cell Carcinoma
Table 5
Impact of PET-CT upon radiotherapy planning in patients with altered identification of involved lymph node levels ().
| | No of patients |
| PET-CT downclassified lymph node levels: | 6 | Lymph node not treated that is unilateral radiotherapy | 1 | Lymph node in prophylactic dose region | 2 | In high-dose region | 2 | Parallel opposed pair hence lymph node in high-dose region | 1 | Overall: likely plan change | 3 |
| PET-CT identified additional FDG-avid lymph node levels: | 14 | Lymph node in high-dose region | 11 | Lymph nodal level in prophylactic dose region | 2 | Parallel opposed pair hence lymph | 1 | node in high-dose region | | Overall: likely plan change | 7 |
|
|